Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Sinopharm Group Co. Ltd.

China VBP, Localization And Other Strategies - How Far And Which Way?

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.

China Commercial

Aurobindo Reverses Roles With Pfizer As It Drops Pin On Indonesia: What’s The Draw?

Aurobindo’s acquisition of 15 brands from Pfizer and Viatris to gain entry to Indonesia marks a role reversal of sorts as Pfizer has been licensing generics from Aurobindo. Scrip takes a look at some of the opportunities and challenges in this growing Southeast Asian market.

Deals Commercial

China's Shrinking Population Poses New Challenge For Pharma

For the first time in 61 years, China has reported its population is shrinking and the new demographic shift is likely to have a far-reaching impact on the pharma sector. Meanwhile, regulators have accelerated the approval of new COVID-19 drugs to relieve acute shortages.

China Approvals

Money, Life And Pursuit Of Paxlovid: Behind China's Mania For Pfizer COVID Drug

From being little known to sought after by millions, Pfizer’s oral antiviral Paxlovid is fast becoming the most pursued medicine in China, amid the largest outbreak of COVID-19 infections the world has yet seen.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Vaccines
  • Other Names / Subsidiaries
    • China National Medical Device Co., Ltd. (CMIC)
    • China National Pharmaceutical Industry Co., Ltd. (Sinopharm CNPIC)
    • China National Scientific Instruments & Materials Corporation (Sinopharm CSIMC)
    • China Sinopharm International Corporation (Sinopharm International)
    • Sinopharm A-THINK Pharmaceutical Co., Ltd
    • Sinopharm Group Company Limited
UsernamePublicRestriction

Register